The Liquid Biopsy market is estimated to be valued at Us$ 13,220.0 Mn or Bn in 2022 and is expected to exhibit a CAGR Of 4.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:
Liquid biopsy utilizes body fluids like blood, urine, and saliva samples for non-invasive detection of cancer. It analyses circulating tumor DNA...